日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial

CPX-351治疗唐氏综合征相关髓系白血病:3期ML-DS 2018试验的结果和预后因素

Laszig, Stephanie; Diederichs, Antonia; Salzmann-Manrique, Emilia; Schuschel, Konstantin; Gonçalves-Dias, José; Issa, Hasan; Miladinovic, Milica; Rettinger, Eva; Wehner, Sibylle; Kreyenberg, Hermann; Bremm, Melanie; Hünecke, Sabine; Kerp, Helena; Waack-Buchholz, Katharina; Thol, Felicitas; Goemans, Bianca F; De Moerloose, Barbara; Boztug, Heidrun; Scheidegger, Nastassja; Pawińska-Wąsikowska, Katarzyna; Reinhardt, Dirk; Klusmann, Jan-Henning

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial

CPX-351 与柔红霉素、阿糖胞苷和吉妥珠单抗治疗老年非不良风险 AML 患者的疗效比较:NCRI AML18 试验

Knapper, Steven; Dillon, Laura W; Babu, Malavika; Thomas, Abin; Thomas, Ian; Hourigan, Christopher S; Andrew, Georgia; Dillon, Richard; Gilkes, Amanda; Marquez Almuina, Nuria; King, Sophie; McCarthy, Nicholas; Bahr, Reem; Al-Ali, Rasha W; Stone, Louisa; Coats, Tom; Byrne, Jennifer; Green, Simone; Overgaard, Ulrik Malthe; Sellar, Rob S; Dennis, Mike; Mehta, Priyanka; Hills, Robert; Freeman, Sylvie D; Russell, Nigel H

Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351

根据 SIE/SIES/GITMO 标准对接受 CPX-351 治疗的 AML-MRC 患者进行体能分类的影响

Palmieri, Raffaele; Guolo, Fabio; Fianchi, Luana; Ferrara, Felicetto; Minetto, Paola; Martelli, Maria Paola; Riva, Carola; Chiusolo, Patrizia; Rondoni, Michela; Capria, Saveria; Minotti, Clara; Pilo, Federica; Perrone, Salvatore; Corbingi, Andrea; Grimaldi, Francesco; De Luca, Giulia; Fili, Carla; Alati, Caterina; Mannelli, Francesco; Lessi, Federica; Marchesi, Francesco; Brunetti, Lorenzo; Capelli, Debora; Piccioni, Anna Lina; Vetro, Calogero; Palumbo, Fanny Erika; Mazzone, Carla; Sperotto, Alessandra; Luzi, Giovanni; Dargenio, Michela; Mariani, Sabrina; Cerrano, Marco; Mulè, Antonino; Di Veroli, Ambra; Meddi, Elisa; Moretti, Federico; Papayannidis, Cristina; Isidori, Alessandro; Ferrari, Antonella; Galimberti, Sara; Cilloni, Daniela; Breccia, Massimo; Lanza, Francesco; Gottardi, Michele; Cairoli, Roberto; Candoni, Anna; Pagano, Livio; Todisco, Elisabetta; Lemoli, Roberto Massimo; Venditti, Adriano; Buccisano, Francesco

Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients

CPX-351治疗的急性髓系白血病患者肛周感染的发生率和特征

Buzzatti, Elisa; Mauro, Cristina; Tesei, Cristiano; Paterno, Giovangiacinto; Palmieri, Raffaele; Esposito, Fabiana; Meddi, Elisa; Moretti, Federico; Zomparelli, Marco; Cardillo, Lucia; Gurnari, Carmelo; Maurillo, Luca; Buccisano, Francesco; Venditti, Adriano; Del Principe, Maria Ilaria

The MAB_3513c gene plays a key role in intrinsic resistance of Mycobacterium abscessus to isoniazid and ethionamide

MAB_3513c基因在脓肿分枝杆菌对异烟肼和乙硫异烟胺的固有耐药性中起关键作用。

Wang, Shuai; Zhang, Xiaofan; Fang, Xiange; Hameed, H M Adnan; Malik, Abdul; Long, Lihua; Gao, Yamin; Fang, Cuiting; Tian, Xirong; Hu, Jinxing; Wang, Xingyue; Feng, Liqiang; Zhang, Tianyu

Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis

CPX-351治疗继发性急性髓系白血病的真实世界经验:与FLAG-IDA方案在倾向评分匹配分析中的比较

Perusini, Maria Agustina; Patiño, Ana Flavia; Andrews, Claire; Assouline, Sarit E; Brandwein, Joseph M; Chow, Signy; Popradi, Gizelle; Sanford, David; Savoie, Lynn; Saini, Lalit; Nadia, Bambace; Khalaf, Dina; Schuh, Andre C; Yee, Karen; Gupta, Vikas; Maze, Dawn; Chan, Steven M; Schimmer, Aaron D; Sabry, Waleed; Sibai, Hassan

Weekend discharge after hip fracture surgery is associated with increased 30-day mortality. A retrospective observational study of 35,138 hip fractures reported to the Norwegian Hip Fracture Register

髋部骨折手术后周末出院与30天死亡率升高相关。一项回顾性观察研究分析了挪威髋部骨折登记处报告的35138例髋部骨折病例。

Boutera, Andrea Toft; Dybvik, Eva; Hallan, Geir; Kristensen, Torbjørn Berge; Gjertsen, Jan-Erik

P-1351. Fosmanogepix Expanded Access Experience in Patients With Fusarium Infections

P-1351. 福斯马诺吉匹在镰刀菌感染患者中的扩大用药经验

Gomes, Guiomar Nascimento; Fernandez, Ricardo; Leite-Dellova, Deise Carla Almeida; Casarini, Dulce Elena; Yanes Cardozo, Licy L; Dadwal, Sanjeet S; Baluch, Aliyah; Dickter, Jana; Newman, Jessica R; Hong Nguyen, M; Weihe, Rachel; Gibson, Joy E; Stemler, Jannik; Schlamm, Haran; Ostrosky-Zeichner, Luis

Corrigendum to "P11-034-25 Efficacy of a Functional Food Supplement With Grape, Soy Protein, and Edamame as an Adjuvant Treatment in the Management of Patients With Hepatitis C."[Current Developments in Nutrition 9, Suppl 2 (2025) 107351:549]

更正“P11-034-25 葡萄、大豆蛋白和毛豆功能性食品补充剂作为丙型肝炎患者辅助治疗的疗效”[Current Developments in Nutrition 9, Suppl 2 (2025) 107351:549]

Mendoza, Luis Galindo; Hoang, Kieu

Olverembatinib (HQP1351): a third-generation tyrosine kinase inhibitor in the treatment of hematologic and solid malignancies-a comprehensive review of clinical outcomes

奥维瑞巴替尼(HQP1351):一种用于治疗血液系统恶性肿瘤和实体瘤的第三代酪氨酸激酶抑制剂——临床结果的全面综述

Sadati, Sina; Yazdizadeh, Sara; Razavi, Seyed Mohsen; Homayoonfal, Mina; Ferns, Gordon A; Divani, Fatemeh; Mirzaei, Hamed